Ginsenoside Rh2 mitigates doxorubicin‐induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer‐bearing mice-Reference-Cited by-同舟云学术

Ginsenoside Rh2 mitigates doxorubicin‐induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer‐bearing mice

Published:2022-05-09 Issue:6 Volume:55 Page:
ISSN:0960-7722
Container-title:Cell Proliferation
language:en
Short-container-title:Cell Proliferation

Author:

Hou Jingang¹,Yun Yeejin²,Cui Changhao³,Kim Sunchang¹²^ORCID

Affiliation:

1. Intelligent Synthetic Biology Center Daejeon Republic of Korea

2. Department of Biological Sciences Korea Advanced Institute of Science and Technology Daejeon South Korea

3. Research and Development Team 4, Sempio Foods Company Cheongju South Korea

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpr.13246

Reference32 articles.

1. Cancer Statistics, 2021

2. Identification of Estrogen-Responsive Genes by Complementary Deoxyribonucleic Acid Microarray and Characterization of a Novel Early Estrogen-Induced Gene:EEIG1

3. Antibody–Drug Conjugates: A Comprehensive Review

4. Analysis of FDA Approved Anticancer Drugs Reveals the Future of Cancer Therapy

5. Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dietary interventions and tumor response to chemotherapy in breast cancer: A comprehensive review of preclinical and clinical data;Clinical Nutrition ESPEN;2024-10

2. Mechanisms of doxorubicin-induced cardiac inflammation and fibrosis; therapeutic targets and approaches;Archives of Biochemistry and Biophysics;2024-09

3. Role of Oxidative Stress and Inflammation in Doxorubicin-Induced Cardiotoxicity: A Brief Account;International Journal of Molecular Sciences;2024-07-08

4. Integrating Chinese medicine into mainstream cancer therapies: a promising future;Frontiers in Oncology;2024-06-18

5. Ginsenosides: an immunomodulator for the treatment of colorectal cancer;Frontiers in Pharmacology;2024-06-12